Literature DB >> 12477765

Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis.

T Ohkusa1, I Okayasu, T Ogihara, K Morita, M Ogawa, N Sato.   

Abstract

BACKGROUND: Bacteria are implicated in certain forms of model chronic colitis but the identity and role of bacteria in human ulcerative colitis (UC) are uncertain. AIMS: To isolate pathogenic bacteria from inflamed mucosa of patients with UC, to examine whether the bacteria have a toxin to Vero cells, and to determine whether the toxin induces UC-like lesions in animals.
METHODS: Bacteria were isolated from UC patients and supernatants from cultures were filtered and tested for cytotoxicity to Vero cells. Bacterial cells producing the cytotoxic supernatants were examined by polymerase chain reaction for verotoxin genes. Culture supernatants of cytotoxic strains were examined by high performance liquid chromatography for organic acid concentrations. Mice were given enemas containing organic acid at the mean concentration in the supernatants of cytotoxic strains to ascertain whether colonic lesions appear in UC.
RESULTS: Only supernatants from cultures of Fusobacterium varium killed Vero cells. Bacterial cells lacked verotoxin genes. Bacterial culture supernatants contained high concentrations of n-butyric acid and the mean concentration (32 mmol/l) was cytotoxic to Vero cells. Twenty four hours after mice were given enemas containing either butyric acid or F varium culture supernatants, colonic ulcers with crypt abscesses, inflammatory cell infiltration, and apoptotic changes were observed.
CONCLUSIONS: Butyric acid in culture supernatants from cultures of F varium caused UC-like lesions in mice. This study indicates that F varium may be one of the elusive pathogenic factors in UC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12477765      PMCID: PMC1773498          DOI: 10.1136/gut.52.1.79

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms.

Authors:  X G Chen; P Correa; J Offerhaus; E Rodriguez; F Janney; E Hoffmann; J Fox; F Hunter; S Diavolitsis
Journal:  Am J Clin Pathol       Date:  1986-11       Impact factor: 2.493

2.  Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis.

Authors:  H von Wulffen; H Rüssmann; H Karch; T Meyer; M Bitzan; T C Kohrt; S Aleksic
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

3.  Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.

Authors:  D A Burke; A T Axon
Journal:  BMJ       Date:  1988-07-09

4.  Attempt to fulfil Koch's postulates for pyloric Campylobacter.

Authors:  B J Marshall; J A Armstrong; D B McGechie; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

5.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

Authors:  I Okayasu; S Hatakeyama; M Yamada; T Ohkusa; Y Inagaki; R Nakaya
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

6.  Surface properties, connective tissue protein binding and Shiga-like toxin production of Escherichia coli isolated from patients with ulcerative colitis.

Authors:  O Olusanya; H Steinrück; P Aleljung; F Ascencio; B Curman; G Järnerot; T Wadström; A Ljungh
Journal:  Zentralbl Bakteriol       Date:  1992-01

7.  Cytotoxic activity of Bacteroides gingivalis and Bacteroides asaccharolyticus.

Authors:  T J van Steenbergen; M D dan Ouden; J J Touw; J de Graaff
Journal:  J Med Microbiol       Date:  1982-05       Impact factor: 2.472

8.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

Authors:  J H Cummings; E W Pomare; W J Branch; C P Naylor; G T Macfarlane
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

9.  Pharmacokinetic profile of imipenem/cilastatin in normal volunteers.

Authors:  G L Drusano; H C Standiford
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

10.  Butyrate: a cytotoxin for Vero cells produced by Bacteroides gingivalis and Bacteroides asaccharolyticus.

Authors:  J J Touw; T J van Steenbergen; J De Graaff
Journal:  Antonie Van Leeuwenhoek       Date:  1982       Impact factor: 2.271

View more
  89 in total

1.  Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.

Authors:  Imane Allali; Susana Delgado; Pablo Isidro Marron; Aurora Astudillo; Jen Jen Yeh; Hassan Ghazal; Saaïd Amzazi; Temitope Keku; M Andrea Azcarate-Peril
Journal:  Gut Microbes       Date:  2015

Review 2.  Probiotics and inflammatory bowel diseases.

Authors:  A-P Bai; Q Ouyang
Journal:  Postgrad Med J       Date:  2006-06       Impact factor: 2.401

3.  Seasonal variations in the onset of ulcerative colitis in Japan.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Hiroaki Saito; Tetsuji Yokoyama; Tomoyoshi Shibuya; Naoto Sakamoto; Kan Uchiyama; Hiroshi Arakawa; Taro Osada; Akihito Nagahara; Sumio Watanabe; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

4.  Human gut microbiome and risk for colorectal cancer.

Authors:  Jiyoung Ahn; Rashmi Sinha; Zhiheng Pei; Christine Dominianni; Jing Wu; Jianxin Shi; James J Goedert; Richard B Hayes; Liying Yang
Journal:  J Natl Cancer Inst       Date:  2013-12-06       Impact factor: 13.506

Review 5.  Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions.

Authors:  Edmund B Chen; Cori Cason; Jack A Gilbert; Karen J Ho
Journal:  J Gastrointest Surg       Date:  2018-04-05       Impact factor: 3.452

6.  Fusobacterium varium in ulcerative colitis: is it population-based?

Authors:  Emma Allen-Vercoe
Journal:  Dig Dis Sci       Date:  2014-10-14       Impact factor: 3.199

7.  Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.

Authors:  Yasushi Yoshimatsu; Akihiro Yamada; Ryuichi Furukawa; Koji Sono; Aisaku Osamura; Kentaro Nakamura; Hiroshi Aoki; Yukiko Tsuda; Nobuo Hosoe; Nobuo Takada; Yasuo Suzuki
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

Review 8.  Microbiome in human immunodeficiency virus infection.

Authors:  January T Salas; Theresa L Chang
Journal:  Clin Lab Med       Date:  2014-09-18       Impact factor: 1.935

9.  Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells.

Authors:  Kentaro Nagaoka; Katsunori Yanagihara; Yosuke Harada; Koichi Yamada; Yohei Migiyama; Yoshitomo Morinaga; Hiroo Hasegawa; Koichi Izumikawa; Hiroshi Kakeya; Masaharu Nishimura; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

Review 10.  The gut microbiota in IBD.

Authors:  Chaysavanh Manichanh; Natalia Borruel; Francesc Casellas; Francisco Guarner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-21       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.